Financials
- Market Capitalization 1.79 B
- Employee 110
- Founded 2024
- CEO N/A
- Website www.inhibrx.com
- Headquarter Delaware, United States
- FIGI BBG01MS5Q9G3
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-10.67
売上高対価格比率
—
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2041 | TSHA Taysha Gene Therapies, Inc. - Common Stock | 5.72 USD | +0.53% | -7.89% | -2.89% | +97.24% | 1.86 B USD | ||
| 2064 | RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.36 USD | -1.18% | -4.82% | +10.89% | -26.80% | 1.80 B USD | ||
| 2070 | SEPN Septerna, Inc. - Common Stock | 38.27 USD | +0.31% | -5.83% | +11.09% | +73.88% | 1.79 B USD | ||
| 2075 | NTLA Intellia Therapeutics, Inc. - Common Stock | 12.64 USD | -0.71% | -7.67% | +19.36% | -7.87% | 1.77 B USD |